CMV prophylaxis with letermovir significantly improves graft and relapse free survival following allogeneic stem cell transplantation

Bone Marrow Transplant. 2024 Jan;59(1):138-140. doi: 10.1038/s41409-023-02124-y. Epub 2023 Oct 19.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acetates*
  • Antiviral Agents / pharmacology
  • Antiviral Agents / therapeutic use
  • Cytomegalovirus
  • Cytomegalovirus Infections* / drug therapy
  • Cytomegalovirus Infections* / prevention & control
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Quinazolines*
  • Stem Cell Transplantation

Substances

  • letermovir
  • Antiviral Agents
  • Acetates
  • Quinazolines